Abstract
Polymeric drugs are defined as polymers that are active pharmaceutical ingredients, i.e., they are neither drug carriers nor prodrugs. In general, the underlying concept behind these therapeutic agents is the utilization of high molecular weight and functional characteristics of polymers to selectively recognize, sequester, and remove low molecular weight and macromolecular disease causing species in the intestinal fluid. The high molecular weight nature of these therapeutically relevant polymers makes them systemically non-absorbed, thus providing a number of advantages including long-term safety profiles over traditional small molecule drug products. Furthermore, multiple functional groups in the polymers incorporate polyvalent binding interactions that can result in pharmaceutical properties not found in small molecule drugs. This article summarizes some of the most recent efforts for the discovery and development of polymeric drugs that have proceeded from discovery phase to market place. Examples include sequestration of low molecular weight species such as bile acids, phosphate, and iron ions as well as polyvalent interactions to bind toxins, viruses, and bacteria as well as polymeric enzyme inhibitors and fat binders as anti-obesity agents. Furthermore, use of functional polymers to treat autoimmune disease and sickle cell anemia has been reviewed.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- GI:
-
gastrointestinal
- SAR:
-
structure-activity relationship
- LDLc:
-
low-density lipoprotein cholesterol
- HMG-CoA:
-
3-hydroxy-3-methyl glutaryl coenzyme A
- BAS:
-
bile acid sequestrant
- C. difficile:
-
Clostridium difficile
- PA:
-
protective antigen
- EF:
-
edema factor
- LF:
-
lethal factor
- Tyr:
-
tyrosine
- Trp:
-
tryptophan
- VAP:
-
viral attachment proteins
- HA:
-
hemagglutinin
- SA:
-
sialic acids
- Kd:
-
dissociation constant
- M:
-
molar
- mM:
-
milli molar
- pM:
-
pico molar
- HIV:
-
human immune virus
- MRSA:
-
methicillin-resistant Staphylococcus aureus
- C. parvus:
-
Cryptosporadium parvum
- VRE:
-
vancomycin-resistant Enterococi
- ROMP:
-
ring opening metathesis polymerization
- S. aureus:
-
Staphylococcus aureus
- RA:
-
rheumatoid arthritis
- MS:
-
multiple sclerosis
- TNF-α:
-
tumor necrosis factor alpha
- GA:
-
glatiramer acetate
- MBP:
-
myelin basic protein
- CNS:
-
central nervous system
- FDA:
-
Food and Drug Administration
- EAE:
-
experimental allergic Encephalomyelitis
- TAG:
-
triacyl glycerides
- PEO:
-
polyethylene oxide
- PPO:
-
polypropylene oxide
References
Scheler W (1987) Makromol Chem Macromol Symp 12:1
Langer R, Tirrell DA (2004) Nature 428:487
Kohn J (1996) Pharm Res 13:815
Jagur-Grodzinki J (1999) React Funct Polymers 39:99
Ringsdorf H (1975) J Polym Sci Polym Symp 51:135
Luo Y, Prestwish GD (2002) Curr Cancer Drug Targets 2:209
Ulbrich K, Pechar M, Strohalm J, Subr V (1997) Makromol Chem Macromol Symp 118:577
Garnett MC (1999) Crit Rev Ther Drug Carrier Sys 16:147
Israel ZH, Domb AJ (1998) Polym Adv Technol 9:799
Gros L, Ringsdorf H, Schupp H (1981) Angew Chemie Int Ed Eng 20:305
Langer R (1998) Nature 392:5
Duncan R (2003) Nature Drug Discovery 2:347
Kuo PT, Hopkins, FT, Wurzel H (1958) Circulation Research 6:178
Regelson W, Holland JF (1962) Clin Pharmcol Ther 3:730
Breslow DS (1976) Pure Appl Chem 46:103
Chirogos MA, Stylos WA (1980) Cancer Res 40:1967
Uglea CV, Panaitescu L (1997) Curr Trends Polym Sci 2:241
Bentolila A, Vlodavsky I, Ishai-Michaeli R, Kovalchuk O, Haloun C, Domb AJ (2000) J Med Chem 43:2591
Dhal PK, Holmes-Farley SR, Mandeville WH, Neenan TX (2004) Encyl Polym Sci Technol. 3rd Edn. Wiley, New York
Johnson LR (1994) Physiology of Gastrointestinal Tract. Raven Press, New York
Braun EJ (2003) Comp Biochem Physiol A: Mol & Int Physiol 136A:499
Perez GO, Oster JR, Pelleya R, Catalis PV, Kem DC (1984) Nephron 36:270
Marrone TJ, Terz KM (1992) J Am Chem Soc 114:7542
Gardiner GW (1997) Can J Gastroenterology 11:573
Gerstman BB, Kirkman R, Platt R (1992) Am J Kidney Dis 20:159
Hsu C (1997) Am J Kidney Dis 29:641
Ribeiro S, Ramos A, Brandao A (1998) Nephrol Dial Transplant 13:2037
Coburn JW, Norris KC, Sherrard DJ, Bia M, Llach F, Alfrey AC, Slatopolsky E (1988) Am J Kidney Dis 12:171
Block G, Hulbert-Shearon T, Levin N (1998) Am J Kidney Dis 31:607
Schmidtchen FP, Berger M (1997) Chem Rev 97:1609
Lehn JM (1988) Angew Chem Int Ed Engl 27:89
Dietrich B, Fyles DL, Fyles TM, Lehn JM (1979) Helv Chim Acta 62:2763
Beer PD, Gale PA (2001) Angew Chem Int Ed Engl 40:487
Sasaki DY, Kurihara K, Kunitake T (1991) J Am Chem Soc 113:9685
Muche M-S, Goebel MW (1996) Angew Chem Int Ed Engl 35:2126
Hider RC, Canas-Rodriguez A (1997) US Patent 5698190 (British)
Holmes-Farley SR, Mandeville WH, Whitesides GM (1996) US Patent 5496545 (Genzyme Corp)
Holmes-Farley SR, Mandeville WH, Whitesides GM (1997) US Patent 5667775 (Genzyme Corp)
Holmes-Farley SR, Mandeville WH (2004) US Patent 6726905 (Genzyme Corp)
Holmes-Farley SR, MandevilleWH, Ward J, Miller KL (1999) J Macromol Sci Pure Appl Chem A36:1085
Chertow GM, Burke SK, Lazarus JM, Stenzel KH, Womboldt D, Goldberg D, Bonventre JV, Slatopolsky E (1997) Am J Kidney Dis 29:66
Slatopolsky E, Burke SK, Dillon MA (1999) Kidney Int 55:299
Amin N (2002) Nephrol Dial Transplant 17:340
Bleyer AJ, Burke SK, Dillon MA (1999) Am J Kidney Dis 33:6694
Qunibi WY, Nolan CR (2004) Kidney Int 90:S33
Bleyer AJ (2003) Exp Opin Pharmacother 4:941
Crichton RR (1991) Inorganic Biochemistry of Iron Metabolism. Ellis Horwood, New York
Halliwell B, Gutteridge JMC (1989) Free Radicals in Biology and Medicine. 2nd edn. Clarendon Press, Oxford, UK
Boldt DH (1999) Am J Med Sci 318:207
Weatherall DJ, Clegg JB (1981) The Thalassaemia Syndromes. 3rd edn. Blackwell Scientific Press, Oxford, UK
Cuthbert JA (1997) J Invest Med 45:518
Liu ZD, Hider RC (2002) Med Res Rev 26:64
Marx JJM (2003) Adv Exper Med Biol 531:57
Porter JB, Jawson MC, Huehns ER, East CA, Hazell JWP (1989) Br J Haematol 73:403
Badman, DG, Bergeron RJ, Brittenham GM (2000) Iron chelators: new development strategies. The Saratoga Group, Florida
Miller MJ (1989) Chem Rev 89:1563
Mandeville WH, Holmes-Farley SR (1994) US Patent 5487888 (Genzyme Corp)
Polomoscanik SC, Cannon CP, Neenan TX, Holmes-Farley SR, Mandeville WH, Dhal PK (2005) Biomacromolecules 6:2946
Grundy SM (1998) Endocrinology and Metabolism Clinics of North America 27:655
Denke MA, Sempos CT, Grundy SM (1993) Arch Int Med 153:1093
(2001) Executive summary of the third report of the “National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.” J Am Med Assoc 285:2486
Rader DJ (2001) Nature Medicine 7:1282
Jamal, SM, Eisenberg MJ, Christopoulos S (2004) Am Heart J 147:956
Brown MS, Goldstein JL (1999) Proc Natl Acad Sci USA 96:11041
Grundy SM (1986) In: Fears R (ed) Pharmacological Control of Hyperlipdaemia. Prous Science Publishers, S.A., Barcelona, Spain, p 3
Stedronsky ER (1994) Biochim et Biophys Acta 1210:255
Mandeville WH, Goldberg DI (1997) Curr Pharm Design 3:15
Grundy S (1987) In: Paoletti R (ed) Drugs Affecting Lipid Metabolism. Springer, Berlin Heidelberg New York, p 34
Huval CC, Bailey MJ, Braunlin WH, Holmes-Farley SR, Mandeville WH, Petersen JS, Polomoscanik SC, Sacchiro RJ, Chen X, Dhal PK (2001) Macromolecules 34:1548
Huval CC, Holmes-Farley SR, Mandeville WH, Sacchiero R, Dhal PK (2004) Eur Polym J 40:693
Zarras P, Vogl O (1999) Prog Polym Sci 24:485
Mandeville WH, Arbeeny C (1999) Idrugs 2:237
Holmes-Farley SR, Mandeville WH, Burke SK, Goldberg DI (2002) US Patent 6423754 (Genzyme Corp)
Holmes-Farley SR, Dhal PK, Petersen JS (1998) US Patent 6203785 (Genzyme Corp)
Zhang L, Janout V, Renner JL, Uragami M, Regen SL (2000) Bioconjug Chem 11:397
Wu G, Brown GR, St-Pierre (1996) Langmuir 12:466
Figuly GD, Royce SD, Khasat NP, Schock LE, Wu SD, Davidson F, Campbell GC, Keating MY, Chen HW, Shimshick EJ, Fischer RT, Grimminger LC, Thomas BE, Smith LH, Gillies PJ (1997) Macromolecules 30:6174
Huval CC, Bailey MJ, Holmes-Farley SR, Mandeville WH, Sacchiero R, Dhal PK (2001) J Macromol Sci Pure Appl Chem A38:1559
Cameron NS, Eisenberg A, Brown GR (2002) Biomacromolecules 3:116
Hainer JW, Hunninghake DB, Benedek IH, Broyles FE, Garner DM, Jenkins RM, McGinn A, Pieniazek HJ, London E, Gillies PJ (1997) Drug Dev Res 41:76
Wong NN Colesevelam (2001) Heart Disease 3:63
Gaudilliere B, Bernardellli P, Berna P (2001) Ann Rep Med Chem 36:293
Bays H, Dujovne C (2003) 4:779
Mammen M, Choi SK, Whitesides GM (1998) Angew Chem Int Ed 37:2754
Borman S (2000) Chem Eng News 78:48
Henderson B, Wilson M, Wren B (1997) Trends in Microbiol 5:454
RauchhausM, Coats AJS, Anker SD (2000) Lancet 356:930
Beutler B, Poltorak A (2001) Critical Care Medicine 29(7 Suppl):S2
Pollack M (1983) Rev Infect Dis 5:S979-984
Coyle EA (2003) Pharmacotherapy 23:638
Bartlett JG (1994) Clin Infec Dis 18:S265
KellyCP, LaMont T (1998) Annu Rev Med 19:375
Spencer RC (1998) J Antimicrob Chemther 41 (Suppl C):5
Alcantara CS, Guerrant RL (2000) Curr Gastroenter Rep 2:310
Taylon NS, Bartlett JG (1980) J Infect Dis 141:92
Bacon-Kurtz C, Fitzpartick R (2001) US Patent 6290946 (Genzyme Corp)
Fitzpatrick R, Huval CC, Bacon-Kurtz CB, Mandeville WH, Neenan TX (2001) US Patent 6290947 (Genzyme Corp)
Braunlin W, Xu Q, Hook P, Fitzpatrick R, Klinger JD, Burrier R, Kurtz CB (2004) Biophys J 87:534
Kiessling LL, Gestwicki JE, Strong LE (2000) Curr Opin Chem Biol 4:696
Kurtz CB, Cannon EP, Brezzani A, Pitruzzello M, Dinardo C, Rinard E, Acheson David WK, Fitzpatrick R, Kelly P, Shackett K, Papoulis AT, Goddard PJ, Barker RH, Palace GP, Klinger JD (2001) J Antimicrob Chemther 45:2340
Nilsson UJ, Heerze LD, Liu YC, Armstrong GD, Palcic MM, Hindsgaul O (1997) Bioconj Chem 8:466
Heerze LD, Armstrong GD (2002) US Patent 6358930
Dixon TC, Meselson M, Guillemin J, Hanna PC (1999) New Engl J Med 341:815
Duesbery NS (1998) Science 280:734
Benson EL, Huynh PD, Finkelstein A, Collier RJ (1998) Biochemistry 37:3941
Mourez M, Kane RS, Mogridge J, Metallo S, Deschatelets P, Sellman BR, Whitesides GM, Collier RJ (2001) Nature Biotechnology 19:958
Gujraty K, Kane RS (2004) AIChe Annual Meeting, Austin, Texas, Poster number 568d
Bukrinskaya AG (1982) Adv Vir Res 27:141
Matrosovich MN (1989) FEBS Letters 252:1
Wiley DC, Skehel JJ (1987) Annu Rev Biochem 56:356
Weinhold EG, Knowles JR (1992) J Am Chem Soc 114:9270
Mammen M, Dahmann G, Whitesides GM (1995) J Med Chem 38:4179
Choi SK, Mammen M, Whitesides GM (1997) J Am Chem Soc 119:4103
Roy R, Zanini D, Meunier SJ, Romanowska A (1993) Chem Commun 213
Matrosovich MN, Mochalova LV, Marinina V, Byramova NE, Bovin NV (1990) FEBS Letters 272:209
Mammen M, Dahmann G, Whitesides GM (1995) J Med Chem 38:4179
Choi SK, Mammen M, Whitesides GM (1996) Chem Biol 3:97
Feltz ET, Regelson W (1962) Nature 196:642
D'cruz OJ, Uckun FM (2004) Curr Pharm Design 10:315
Kotra LP, Golemi D, Vakulenko S, Mobashery S (2000) Chem Ind 10:341
Pearson H (2002) Nature 418:469
Walsh C (2000) Nature 406:775
Reid G, Sobel JD (1987) Rev Infect Dis 9:470
Mandeville WH, Garigapati VR (1997) US Patent 5700458 (Genzyme Corp)
Maloy WL, Kari UP (1995) Biopolymers 37:105
Mandeville WH, Neenan TX, Holmes-Farley SR (1998) US Patent 6034129 (Genzyme Corp)
Matukaitis JM (1997) J Commun Health Nurs 14:135
Arimoto H, Nishimura K, Kinuki T, Hayakawa I, Uemura D (1999) Chem Commun 1361
Arimoto H, Oishi T, Nishijima M, Kinumi T (2001) Tetra Lett 42:3347
Sundram UN, Griffin JH, Nicas TI (1996) J Am Chem Soc 118:13107
Klein L, Klugman M, Nave K, Tuohy V, Kyewski B (2000) Nature Med 6:56
Firestein GS (2003) Nature 423:356
Compton DA (1998) McAlpine's Multiple Sclerosis. 3rd edn. Churchill Livingstone, New York
Goodin DS (2000) Exp Opin Invest Drugs 9:655
Hall GL, Compston A, Scolding NJ (1997) Trends Neurosci 20:63
Donoghue S, Greenlees C (2000) Exp Opin Invest Drugs 9:167
Rudick RA (1999) Arch Neurol 56:1079
Sela M (1998) Acta Polym 49:523
Fricker J (1998) Lancet 351:1792
Teitelbaum D, Arnon R, Sela M (1999) Proc Natl Acad Sci USA 96:3842
Johnson KP, Brooks BR, Ford CC, Goodman A, Guarnaccia J et al. (2000) Multiple Sclerosis 6:255
Fridkis-Hareli M, Santambrogio L, Stern JNH, Fugger L, Brosnan C, Strominger JL (2002) J Clin Invest 109:1635
Strominger JL, Fridkis-Hareli M (2004) US Patent Appl 20040038887 (Harvard Univ)
Stern JNH, Illes Z, Reddy J, Keskin DB, Sheu E, Fridkis-Hareli M, Nishimura H, Brosnan CF, Santambroigo L, Kuchroo VK, Strominger JL (2004) Proc Natl Acad Sci USA 101:11743
Illes Z, Stern JNH, Reddy J, Waldner H, Mycko MP, Brosnan CF, Ellmerich S, Altmann DM, Santambroigio L, Strominger JL, Kuchroo VK (2004) Proc Natl Acad Sci USA 101:11749
Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL (1998) Proc Natl Acad Sci USA 95:12528
Clapham JC, Arch JRS, Tadayyon M (2001) Pharmacol Therap 89:81
Wofford MR, Hall JE (2004) Curr Pharm Design (2004) 10:3621
Shi Y, Burn P (2004) Nature Rev Drug Disc 3:695
Halford JCG (2004) Current Drug Targets 5:637
Bray GA, Tartaglia LA (2000) Nature 404:672
Campfield LA, Smith FJ, Burn P (1998) Science 280:1383
Phan CT, Tso P (2001) Front Biosci 6:D299
Gargouri Y, Ransac S, Verger R (1997) Biochim Biophys Acta 1344:6
Hadvary P, Lengfeld H, Wolfer H (1988) Biochem J 256:357
Halpern A (2003) Prog Obes Res 9:1045
Ballinger A, Peikin SR (2002) Eur J Pharmacol 440:109
Harp JB (1998) J Nutr Biochem 9:516
Spanswick D, Lee K (2003) Expert Opin Emerging Drugs 8:217
Lowe ME (1994) Gastroenterology 107:1524
Jozefiak TH, Mandeville WH, Holmes-Farley SR, Arbeeny C, Huval CC, Sacchiero R, Concagh D, Yang K, Maloney C (2001) Polym Prepr 42(2):98
Jozefiak T, Holmes-Farley SR, Mandeville WH, Huval CC, Garigapati VR,Shackett KK, Concagh D (2001) US Patent 6299868 (Genzyme Corp)
Mandeville WH, Whitesides GM, Holmes-Farley SR (2001) US Patent 6264937 (Genzyme Corp)
Holmes-Farley SR (2003) PCT Int Appl WO 2003002130 (Genzyme Corp)
Holmes-Farley SR, Mandeville WH, Dhal PK, Huval CC, Li X, Polomoscanik SC (2003) PCT Int Appl WO 2003002571 (Genzyme Corp)
Rodgers GP, Noguchi CT, Schechter AN (1994) Sci Am Sci & Med 1:48
Persons DA (2003) Cur Opin Mol Ther 5:508
Smith CM, Hebbel RP, Tukey DP, Clawson CC, White JG, Vercellotti GM (1987) Blood 69:1631
Patrickios CS, Georgiou TK (2003) Cur Opin Col Inter Sci 8:76
Schmolka IR (1977) J Am Oil Chem Soc 54:110
Kabanov AV, Batrakova EV, Alakhov VY (2002) J Contr Rel 82:189
Gibbs WJ, Hagemann TM (2004) Ann Pharmacother 38:320
Orringer EP et al. (2001) JAMA 286:2099
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Dhal, P.K., Holmes-Farley, S.R., Huval, C.C., Jozefiak, T.H. Polymers as Drugs. In: Satchi-Fainaro, R., Duncan, R. (eds) Polymer Therapeutics I. Advances in Polymer Science, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/12_020
Download citation
DOI: https://doi.org/10.1007/12_020
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29210-4
Online ISBN: 978-3-540-32945-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)